Vladimir Krystof

Olomouc, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 109 publications

Correction: Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activity.

Correction: Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activity.

Journal: Frontiers in pharmacology

Published: May 30, 2026

Structure-guided identification and characterization of a novel pyrazolo[1,5-a]pyrimidine ligand of SARS-CoV-2 main protease.

Structure-guided identification and characterization of a novel pyrazolo[1,5-a]pyrimidine ligand of SARS-CoV-2 main protease.

Journal: International journal of biological macromolecules

Published: March 03, 2026

Attack of NADH and ascorbate toward metal-activated ligand of organoiridium(III) compound.

Attack of NADH and ascorbate toward metal-activated ligand of organoiridium(III) compound.

Journal: Journal of inorganic biochemistry

Published: February 13, 2026

First-in-Class Dual PDGFR/Carbonic Anhydrase IX/XII Inhibitors: 6,7-Dimethoxyquinoline-Sulfonamides as Promising Antileukemic Agents.

First-in-Class Dual PDGFR/Carbonic Anhydrase IX/XII Inhibitors: 6,7-Dimethoxyquinoline-Sulfonamides as Promising Antileukemic Agents.

Journal: Journal of medicinal chemistry

Published: January 26, 2026

A patent review of Mpro protease inhibitors for the treatment of COVID-19 infections (2020 - present).

A patent review of Mpro protease inhibitors for the treatment of COVID-19 infections (2020 - present).

Journal: Expert opinion on therapeutic patents

Published: December 05, 2025

Synthesis and antimitotic activity of 2-phenyl-6-pyridinyl-2H-pyrazolo[4,3-c]pyridines.

Synthesis and antimitotic activity of 2-phenyl-6-pyridinyl-2H-pyrazolo[4,3-c]pyridines.

Journal: RSC advances

Published: November 28, 2025

Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activity.

Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activity.

Journal: Frontiers in pharmacology

Published: November 12, 2025

Cytotoxicity and Antimicrobial Activity of GaMF1 Analogs.

Cytotoxicity and Antimicrobial Activity of GaMF1 Analogs.

Journal: ChemMedChem

Published: October 22, 2025

Development of New Pyrazolo [3,4-b]Pyridine Derivatives as Potent Anti-Leukemic Agents and Topoisomerase IIα Inhibitors with Broad-Spectrum Cytotoxicity.

Development of New Pyrazolo [3,4-b]Pyridine Derivatives as Potent Anti-Leukemic Agents and Topoisomerase IIα Inhibitors with Broad-Spectrum Cytotoxicity.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 16, 2025

The methioninase from the alkalithermophile Thermobrachium celere possesses suitable properties for treatment of cancer.

The methioninase from the alkalithermophile Thermobrachium celere possesses suitable properties for treatment of cancer.

Journal: International journal of biological macromolecules

Published: July 01, 2025

3D-QSAR Design of New Bcr-Abl Inhibitors Based on Purine Scaffold and Cytotoxicity Studies on CML Cell Lines Sensitive and Resistant to Imatinib.

3D-QSAR Design of New Bcr-Abl Inhibitors Based on Purine Scaffold and Cytotoxicity Studies on CML Cell Lines Sensitive and Resistant to Imatinib.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 20, 2025

Preparation and biological activity of isoperrottetin A and its phosphonium salts derivatives.

Preparation and biological activity of isoperrottetin A and its phosphonium salts derivatives.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: March 19, 2025

Showing 1-12 of 109

Last Updated: 09/26/2026